July 13, 2021
“Baidu (NASDAQ: BIDU)… …Overall, 17 Wall Street analysts have weighed in on Baidu shares in the past three months, giving the stock 14 Buys and 3 Holds for a Strong Buy consensus rating. The average Baidu price target of $304.40 implies approximately 67.8% upside… Continue Reading…
June 23, 2021
“Everi Holdings (EVRI)… Everi has a unanimous Strong Buy analyst consensus rating, showing that Bain’s view is no outlier. That consensus is based on 7 recent reviews of the stock. The shares are currently priced at $24.69, and recent gains… Continue Reading…
May 27, 2021
“RedHill Biopharma (RDHL)… Overall, based on all the above factors, Wall Street analysts are thoroughly impressed with RDHL. It boasts 100% Street support, or 4 Buy ratings in the last three months, making the consensus a Strong Buy. Shares are selling… Continue Reading…
March 25, 2021
“Oncolytics Biotech (ONCY)… Turning now to the rest of the Street, other analysts are on the same page. With 5 Buys and no Holds or Sells, the word on the Street is that ONCY is a Strong Buy. Given its… Continue Reading…
March 19, 2021
“Splunk, Inc. (SPLK)… The majority of the Street concurs, as among the 17 analysts to have published a call on SPLK over the last 3 months, 10 say Buy and 7 suggest Hold. SPLK’s Moderate Buy consensus rating is accompanied… Continue Reading…
March 9, 2021
“On24 (ONTF)… Sometimes, a company is just so solid and successful that Wall Street’s analysts line up right behind it – and that is the case here. The Strong Buy analyst consensus rating is unanimous, based on 8 Buy-side reviews published… Continue Reading…
December 3, 2020
“Cinedigm Corporation (CIDM)… Currently, CIDM has 2 reviews on record, making the stock a Moderate Buy. The shares are selling for 53 cents, and the $2.75 average price target suggests an impressive 418% upside on the one-year time horizon… Kubient (KBNT)… To… Continue Reading…
November 13, 2020
“Sequans Communications (SQNS)… Sequans holds a unanimous Strong Buy rating from the analyst consensus, based on 4 Buy reviews given in the last two months. Furthermore, the average price target suggests it will more than double, growing by 148% from… Continue Reading…
October 20, 2020
“Neos Therapeutics (NEOS)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, NEOS has a Strong Buy consensus rating. At $8.33, the average price target… Continue Reading…
October 14, 2020
“Silicon Motion (SIMO)… Turning to the rest of the Street, the bulls have it on this one. With 4 Buys and a lone Hold, the word on the Street is that SIMO is a Strong Buy. At $49.60, the average… Continue Reading…
Recent Comments